Arthritis and Rheumatology

Journal

Publication Venue For

  • Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.  71:529-541. 2019
  • Pain Susceptibility Phenotypes in Those Free of Knee Pain With or at Risk of Knee Osteoarthritis: The Multicenter Osteoarthritis Study.  71:542-549. 2019
  • Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.  71:451-459. 2019
  • Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.  71:281-289. 2019
  • Risk of Knee Osteoarthritis With Obesity, Sarcopenic Obesity, and Sarcopenia.  71:232-237. 2019
  • Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.  71:143-153. 2019
  • Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.  71:5-32. 2019
  • Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al.  70:2098-2099. 2018
  • Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.  70:2077-2086. 2018
  • Brief Report: Leg Length Inequality and Hip Osteoarthritis in the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.  70:1572-1576. 2018
  • Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.  70:1654-1660. 2018
  • Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study.  70:1565-1571. 2018
  • Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.  70:1508-1518. 2018
  • Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.  70:1144-1154. 2018
  • Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.  70:963-970. 2018
  • Editorial: STATus of STAT3 in Psoriatic Arthritis.  70:801-804. 2018
  • Transcriptional Profiling of Synovial Macrophages Using Minimally Invasive Ultrasound-Guided Synovial Biopsies in Rheumatoid Arthritis.  70:841-854. 2018
  • Reply.  70:795-796. 2018
  • High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy.  70:594-605. 2018
  • Brief Report: Validation of a Definition of Flare in Patients With Established Gout.  70:462-467. 2018
  • The Science Behind Biosimilars: Entering a New Era of Biologic Therapy.  70:334-344. 2018
  • Reply.  70:320. 2018
  • 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.  69:2271-2282. 2017
  • Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study.  69:2386-2395. 2017
  • Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.  69:2351-2358. 2017
  • Response to the American College of Physicians Osteoporosis Guideline, 2017 Update.  69:2097-2101. 2017
  • Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.  69:1960-1968. 2017
  • Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States.  69:1733-1740. 2017
  • 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.  69:1538-1551. 2017
  • Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis.  69:1054-1066. 2017
  • Reply.  69:1122. 2017
  • Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al.  69:863-865. 2017
  • Brief Report: Partial- and Full-Thickness Focal Cartilage Defects Contribute Equally to Development of New Cartilage Damage in Knee Osteoarthritis: The Multicenter Osteoarthritis Study.  69:560-564. 2017
  • Coronary Artery Calcification and Rheumatoid Arthritis: Lack of Relationship to Risk Alleles for Coronary Artery Disease in the General Population.  69:529-541. 2017
  • Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.  69:362-375. 2017
  • Genome-Wide Association Study of Radiographic Knee Osteoarthritis in North American Caucasians.  69:343-351. 2017
  • Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases.  69:439-446. 2017
  • Multiple Nonspecific Sites of Joint Pain Outside the Knees Develop in Persons With Knee Pain.  69:335-342. 2017
  • Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.  69:46-57. 2017
  • Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).  69:203-212. 2017
  • The Association of Vibratory Perception and Muscle Strength With the Incidence and Worsening of Knee Instability: The Multicenter Osteoarthritis Study.  69:94-102. 2017
  • Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.  68:2612-2617. 2016
  • Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.  68:2403-2411. 2016
  • Reply.  68:2564. 2016
  • Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein–Enriched Serum in Rheumatoid Arthritis.  68:2099-2105. 2016
  • Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.  68:2328-2337. 2016
  • Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy–Induced Osteoporosis Treated With Alendronate or Teriparatide.  68:2122-2128. 2016
  • A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.  68:1932-1944. 2016
  • Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.  68:2035-2043. 2016
  • Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain.  68:1669-1676. 2016
  • Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.  68:1384-1391. 2016
  • Regulation of Effector Treg Cells in Murine Lupus.  68:1454-1466. 2016
  • Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans.  68:1197-1209. 2016
  • Reply.  68:1316-1318. 2016
  • X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome.  68:1290-1300. 2016
  • Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture.  68:932-943. 2016
  • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.  68:566-576. 2016
  • Association of Joint Inflammation with Pain Sensitization in Knee Osteoarthritis: The Multicenter Osteoarthritis Study.  68:654-661. 2016
  • Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset with Disease Course in Juvenile Myositis.  68:761-768. 2016
  • Association of Triple Therapy with Improvement in Cholesterol Profiles over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.  68:577-586. 2016
  • Risk Factors for Targeted Fungal and Mycobacterial Infections in Patients Taking Tumor Necrosis Factor Inhibitors.  68:597-603. 2016
  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.  68:1-26. 2016
  • Comparative Risk of Hospitalized Infection Associated with Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.  68:56-66. 2016
  • Editorial: A Novel Genetic Association with Systemic Sclerosis: The Utility of Whole-Exome Sequencing in Autoimmune Disease.  68:27-30. 2016
  • Risk of Subsequent Infection among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.  68:67-76. 2016
  • A randomized trial comparing disease activity measures for the assessment and prediction of response in rheumatoid arthritis patients initiating certolizumab pegol.  67:3104-3112. 2015
  • Patterns of coexisting lesions detected on magnetic resonance imaging and relationship to incident knee osteoarthritis: The multicenter osteoarthritis study.  67:3158-3165. 2015
  • 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.  67:2557-2568. 2015
  • Brief report: Expression of interferon-γ receptor genes in peripheral blood mononuclear cells is associated with rheumatoid arthritis and its radiographic severity in african americans.  67:1165-1170. 2015
  • Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: A consortium of rheumatology researchers of North America registry study.  67:1995-2003. 2015
  • Disease activity in rheumatoid arthritis and the risk of cardiovascular events.  67:1449-1455. 2015
  • Editorial: The road traveled: Genomics and biomarkers in antineutrophil cytoplasmic antibody-associated vasculitis.  67:1700-1702. 2015
  • Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study.  67:1837-1847. 2015
  • Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.  67:1062-1073. 2015
  • Racial/ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: A Hispanic and asian paradox.  67:752-760. 2015
  • Randomized, double-blind, placebo-controlled trial of the effect of vitamin D<inf>3</inf> on the interferon signature in patients with systemic lupus erythematosus.  67:1848-1857. 2015
  • Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab.  67:1456-1464. 2015
  • The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and netosis.  67:2323-2334. 2015
  • Primary Sjögren's Syndrome Is Characterized by Distinct Phenotypic and Transcriptional Profiles of IgD+ Unswitched Memory B Cells.  66:2558-2569. 2014
  • Arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritis doing as well?.  66:250-253. 2014
  • Brief report: A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.  66:1882-1887. 2014
  • CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model.  66:990-999. 2014
  • Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients.  66:3160-3169. 2014
  • Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis.  66:497-507. 2014
  • End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.  66:390-396. 2014
  • Erratum: Incorrect values for intractable and cluster headaches at enrollment shown in figure 1 and incorrect prevalence of headache at ten years in text of the article by hanly et al (Arthritis and Rheumatology (2013)).  66:1671. 2014
  • Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans.  66:1291-1299. 2014
  • HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: Hierarchical classification systems, amino acid positions, and residues.  66:3274-3282. 2014
  • Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis.  66:2368-2379. 2014
  • Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice.  66:2601-2612. 2014
  • Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.  66:2871-2880. 2014
  • Periodontitis and porphyromonas gingivalis in patients with rheumatoid arthritis.  66:1090-1100. 2014
  • Racial and ethnic differences in older adults with knee osteoarthritis.  66:1800-1810. 2014
  • International Standard Serial Number (issn)

  • 2326-5191
  • Electronic International Standard Serial Number (eissn)

  • 2326-5205